首页> 外文OA文献 >PCN22 EFFICACY AND CARDIAC SAFETY OF TRASTUZUMAB (T) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY-STAGE BREAST CANCER: A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

【2h】

PCN22 EFFICACY AND CARDIAC SAFETY OF TRASTUZUMAB (T) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY-STAGE BREAST CANCER: A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

机译：曲妥珠单抗（T）在HER2阳性早期乳腺癌辅助治疗中的PCN22疗效和心脏安全性：系统评价（SR）和meta分析（MA）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Botrel TEA; Clark O; Clark LGO; Paladini L; Faleiros E; Pegoretti B;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 曲妥珠单抗对30例Her2阳性中国乳腺癌患者术后辅助治疗安全性的初步观察 [J] . 周宁宁, 滕小玉, 刘冬耕, 癌症（英文版） . 2008,第012期
2. Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis [J] . Yu-Tuan Wu, Zhou Xu, Ke Zhang, Therapeutics and Clinical Risk Management . 2018,第2期

机译：曲妥珠单抗和蒽环类新辅助化疗同时治疗HER2阳性乳腺癌的疗效和心脏安全性：系统评价和荟萃分析
3. Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis [J] . Anne Julienne Genuine, Usa Chaikledkaew, Due Ong The, Expert review of clinical pharmacology . 2019,第7a12期

机译：佐剂曲妥珠单抗为Her2阳性早期乳腺癌的方案：系统审查和荟萃分析
4. Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials [J] . Ning Li, Xiao-jing Tie, Xin Gao, BMJ Open . 2017,第3期

机译：拉帕替尼和曲妥珠单抗治疗HER2阳性乳腺癌的有效性和安全性：随机对照试验的系统评价和荟萃分析
5. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
6. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
7. Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis [O] . Yu-Tuan Wu, Zhou Xu, Ke Zhang, 2018

机译：曲妥珠单抗和蒽环类新辅助化疗同时治疗HER2阳性乳腺癌的疗效和心脏安全性：系统评价和荟萃分析
8. Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis [O] . Yu-Tuan Wu, Zhou Xu, Ke Zhang, 2018

机译：曲妥珠单抗和基于蒽环素的新辅助化疗对HER2阳性乳腺癌的疗效和心脏安全性：系统评价和荟萃分析

PCN22 EFFICACY AND CARDIAC SAFETY OF TRASTUZUMAB (T) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY-STAGE BREAST CANCER: A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

著录项

引文网络

相似文献

相关主题

期刊订阅